Share on StockTwits

Cynosure (NASDAQ:CYNO) is scheduled to release its Q214 earnings data on Tuesday, July 29th. Analysts expect Cynosure to post earnings of $0.29 per share and revenue of $71.15 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Cynosure (NASDAQ:CYNO) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.19 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.23 by $0.04. The company had revenue of $62.00 million for the quarter, compared to the consensus estimate of $64.70 million. During the same quarter last year, the company posted $0.12 earnings per share. Cynosure’s revenue was up 52.3% compared to the same quarter last year. On average, analysts expect Cynosure to post $1.25 EPS for the current fiscal year and $1.50 EPS for the next fiscal year.

Cynosure (NASDAQ:CYNO) traded down 1.96% on Monday, hitting $19.46. 81,986 shares of the company’s stock traded hands. Cynosure has a 52 week low of $19.00 and a 52 week high of $31.48. The stock’s 50-day moving average is $20.97 and its 200-day moving average is $25.0. The company’s market cap is $434.3 million.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Cynosure from an “underperform” rating to a “neutral” rating in a research note on Tuesday, July 8th. They now have a $21.70 price target on the stock. On the ratings front, analysts at TheStreet downgraded shares of Cynosure from a “buy” rating to a “hold” rating in a research note on Thursday, May 8th. Finally, analysts at Maxim Group cut their price target on shares of Cynosure from $39.00 to $35.00 in a research note on Wednesday, May 7th. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $32.93.

Cynosure Inc (NASDAQ:CYNO) develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.